Vivos Inc. (OTCMKTS:RDGL – Get Free Report) was up 8.3% during trading on Monday . The company traded as high as $0.13 and last traded at $0.11. Approximately 1,096,929 shares were traded during mid-day trading, an increase of 12% from the average daily volume of 982,749 shares. The stock had previously closed at $0.10.
Vivos Price Performance
The stock has a market cap of $48.97 million, a price-to-earnings ratio of -10.80 and a beta of 0.88. The firm has a 50 day simple moving average of $0.12 and a two-hundred day simple moving average of $0.12.
About Vivos
Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.
Featured Articles
- Five stocks we like better than Vivos
- Using the MarketBeat Dividend Tax Calculator
- AST SpaceMobile: 5 Reasons to Buy This Tiny Trailblazer Stock
- Canada Bond Market Holiday: How to Invest and Trade
- Why Call Option Traders Are Targeting This Dividend ETF Now
- What is the Hang Seng index?
- Is Alphabet Misunderstood? Here’s Why the Bulls Are Buying
Receive News & Ratings for Vivos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivos and related companies with MarketBeat.com's FREE daily email newsletter.
